| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
Modeling Product Development and Protocol Execution Risk as a Tool for Optimizing Productivity | |
| |
May 25, 2006 |
|
|
| |
|
|
| |
|
|
|
Drug Information Association, Online
Jun 7 2006
As drug development becomes ever more complicated, the risk for clinical trial failure steadily increases. Being able to identify, predict and manage the risks that could lead to problems during protocol execution, product development or launch is critical to success. By successfully identifying and predicting risk throughout the development program, an R&D organization increases the probability for successfully addressing those risks and resolving them at the earliest stage. During this Webinar, we will discuss new methods for identifying and reducing risk in protocols and product development.
|
|
|
|
|
|
|
|
Organized by:
|
|
Drug Information Association |
|
|
Invited Speakers:
|
|
DAVE ZUCKERMAN
President, Customized Improved StrategiesRIICK SAX,, MD
Vice President, Global Medical Science
AstraZeneca
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.diahome.org/product/11358/06227.pdf
|
|
|
E-mail:
|
|
dia@diahome.org
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|